Effects of Bromfenac Ophthalmic Solution on Intraocular Pressure in Cataract Patients Undergoing Phacoemulsification
Abstract
Background: Cataract surgery is one of the most common surgeries, and changes in intraocular pressure might occur after cataract surgery, and some postoperative medications might affect it.
Objectives: Evaluate the effects of the non-steroidal anti-inflammatory drug bromfenac 0.09% ophthalmic solution on intraocular pressure (IOP) after phacoemulsification surgery and report any side effects of the drug.
Patient and Method: This is a prospective study done in an ophthalmic center in Iraq involving adult patients with senile or iatrogenic cataracts prepared for cataract surgery by phacoemulsification with intraocular lens (IOL) implantation and were divided into two groups: Group one: who received 0.09% bromfenac ophthalmic solution twice daily in addition to Moxifloxacin 0.5% ophthalmic drops every 6 hours and Dexamethasone phosphate 0.1% ophthalmic drops every 4-6 hours post-operatively.Group two: who received only Moxifloxacin 0.5% every 6 hours and Dexamethasone phosphate 0.1% ophthalmic drops every 4-6hrs without the administration of bromfenac 0.09% ophthalmic drops post-operatively.Results: Eighty-seven eyes of 87 patients are enrolled in the study; the preoperative mean of intraocular pressure in group one and group two were 16.58 ± 2.37 mmHg and 17.14 ± 3.33 mmHg, respectively, with a p-value of 0.365, while the postoperative mean of intraocular pressure in group one and group two was 16 ± 2.32 mmHg and 16.68 ± 2.9 mmHg, respectively, with a p-value of 0.266, and all…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.